about
Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradationApplication of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signalingEffective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerizationViral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis.Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.Herpes simplex virus type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitroKaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis.Phosphorylation of the cyclin-dependent kinase inhibitor p21Cip1 on serine 130 is essential for viral cyclin-mediated bypass of a p21Cip1-imposed G1 arrest.Cyclin-dependent kinase 6 phosphorylates NF-κB P65 at serine 536 and contributes to the regulation of inflammatory gene expression.Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.Oncogenic Herpesvirus Utilizes Stress-Induced Cell Cycle Checkpoints for Efficient Lytic ReplicationKaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivoCell signaling pathways engaged by KSHV.p53 reactivation kills KSHV lymphomas efficiently in vitro and in vivo: new hope for treating aggressive viral lymphomas.Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition.KSHV viral cyclin binds to p27KIP1 in primary effusion lymphomas.Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6.Whole-Genome Sequencing Identifies STAT4 as a Putative Susceptibility Gene in Classic Kaposi Sarcoma.Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56.Naughty chaperone as a target for viral cancer.A novel virus-host cell membrane interaction. Membrane voltage-dependent endocytic-like entry of bacteriophage straight phi6 nucleocapsid.Bacteriophage phi 6 envelope elucidated by chemical cross-linking, immunodetection, and cryoelectron microscopy.KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas.Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.Kaposi (KS) pathogenesis: cell origin, HHV-8 permissiveness, proliferation, genomic instability.[Viral infection--a diverse causative agent of cancer].Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.[Encouraging experiences of interactive lectures].Purified phi 6 nucleocapsids are capable of productive infection of host cells with partially disrupted outer membranes.Lymphatic endothelium stimulates melanoma metastasis and invasion via MMP14-dependent Notch3 and β1-integrin activation.MMP16 Mediates a Proteolytic Switch to Promote Cell-Cell Adhesion, Collagen Alignment, and Lymphatic Invasion in Melanoma.In Vitro Transcription of the Double-Stranded RNA Bacteriophage φ6 Is Influenced by Purine NTPs and CalciumNTP Binding Induces Conformational Changes in the Double-Stranded RNA Bacteriophage ø6 Subviral ParticlesOncogenic herpesvirus engages endothelial transcription factors SOX18 and PROX1 to increase viral genome copies and virus production
P50
Q24293167-FDE8AFA3-7A93-4115-B1B8-FD761BF85B39Q24309408-EDA3DA28-FD45-48AE-91A1-731FA14BDD84Q24311715-CA83C27F-5D75-4B7B-BBF7-D1FE423E0E9BQ33301012-15CB284D-26E1-4CB2-BD10-935270A18618Q33545232-43FA9834-DAE3-476E-8FF9-64581216C8B7Q33964524-05C6F095-19D4-4895-B54B-9D74FC92C3D7Q34102689-E61766FF-CC96-4EC9-BC88-06FB773397F4Q34519840-2D19590B-A2F3-4C54-9AB5-BDBA31640382Q34540259-497A2EEB-5F9F-4D26-AB28-D912802022EEQ35664106-A807C251-6B9F-42A1-8B68-AB5F88E23DA8Q35927487-F65F668A-CA7A-47D0-AEF8-552CBEF3EA0EQ36023151-6A93C0CD-86F0-4E56-A1F6-8F650D20CDB6Q36185745-EE020254-A2CF-4A4D-84AA-6D8D819161CAQ36531004-A3AB8803-DA7C-4F54-BFAE-49FD43E8AAB8Q36949655-4D91B343-9E12-4997-9931-D4526A8264C7Q38184249-80AD6AFD-436F-4324-97A6-26C448DE11BEQ39426922-8EDB6B7F-1683-46FD-88DB-E87F0D8F9F33Q40532287-6BFE8279-75DB-44E9-B03F-BBC148AD208DQ40923261-990935B9-A959-4685-994C-FBEBBAA13867Q41607208-D32764F8-6D8A-443A-A797-B0C80F3AE2B3Q42152408-29217898-6091-4DA1-836C-F66D3DF9E941Q42261638-F617C905-F308-45E2-A589-BE2FFD8F1924Q42860679-F46274C9-E280-43DF-8AD7-2E6EA48387F7Q44060533-850048EF-589F-4974-85A8-E6DA297A0323Q44995230-97463989-F42B-4029-BF78-BBDD43096144Q45358610-4FA6F884-479D-4743-BF4F-59D916ADE044Q46146065-D466A94D-B834-4EF6-AACD-196AA7876AE2Q46924263-29A6E5EC-306B-42B1-A11F-98F6B28AFCE6Q47612817-33C5347E-ADD0-46EA-9557-77BA92A5209BQ51920718-D37979E8-50FC-4C82-BF4A-EB5C3C7C895CQ52483946-DF6BE032-A386-46FC-AD93-9DCA08A8A12BQ52715474-B76E3E76-E59C-4A17-9E8C-F622A4510C42Q55058972-099FB79F-F110-4AEA-B485-98AE1A751167Q58300040-E70AC349-1CA3-4038-8E1E-1A52C062FB10Q58300052-AA7F3845-3548-49C1-84AE-42A0D48702D4Q96229486-98E75EDF-B1E0-4293-B89D-7675E0B5AE03
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Päivi M Ojala
@ast
Päivi M Ojala
@en
Päivi M Ojala
@es
Päivi M Ojala
@nl
Päivi M Ojala
@sl
type
label
Päivi M Ojala
@ast
Päivi M Ojala
@en
Päivi M Ojala
@es
Päivi M Ojala
@nl
Päivi M Ojala
@sl
prefLabel
Päivi M Ojala
@ast
Päivi M Ojala
@en
Päivi M Ojala
@es
Päivi M Ojala
@nl
Päivi M Ojala
@sl
P106
P31
P496
0000-0001-9065-1832